|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Operating Activities: | |||
| Net loss | |||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Non-cash lease expense | |||
| Depreciation and amortization | |||
| Stock-based compensation | |||
| Provision for uncollectible accounts | |||
| Unrealized exchange gain | |||
| Unrealized exchange gain (loss) | |||
| Unrealized exchange gain (loss) and other | |||
| Provision for inventory | |||
| Change in fair value of warrant liabilities | |||
| Change in fair value of derivative liabilities | |||
| Change in fair value of debt | |||
| Change in fair value of Revenue Interest Financing and PIPE Conversion Option | |||
| Change in fair value of earn-out liabilities | |||
| Change in fair value of RTW Share Obligation | |||
| Interest paid on debt recorded at fair value | |||
| Non-cash interest expense | |||
| Non-cash termination of convertible note side letters | |||
| Loss on extinguishment of debt | |||
| Non-cash issuance of common stock for commitment shares | |||
| Debt issuance costs associated with debt recorded at fair value | |||
| Issuance costs associated with warrants recorded at fair value | |||
| Changes in operating assets and liabilities: | |||
| Accounts receivable | |||
| Inventory | |||
| Prepaid expenses, other current and long-term assets | |||
| Lease liabilities | |||
| Accounts payable | |||
| Accrued expenses and other current liabilities | |||
| Net cash used in operating activities | |||
| Investing Activities: | |||
| Purchases of property and equipment | |||
| Net cash used in investing activities | |||
| Financing Activities: | |||
| Proceeds from issue of convertible notes | |||
| Proceeds from private offerings, net of issuance costs | |||
| Proceeds from public offerings, net of issuance costs | |||
| Proceeds from term loan - net | |||
| Payment of debt issuance costs | |||
| Proceeds from Business Combination, net of transaction costs | |||
| Proceeds from revenue interest financing | |||
| Repayment of Term Loan | |||
| 2021 Term Loan | |||
| Fortress Term Loan | |||
| Repayment of promissory note assumed in Business Combination | |||
| Repayment of Fortress Term Loan | |||
| Proceeds from option and warrant exercises | |||
| Repayment of convertible notes | |||
| Proceeds from equity line financing | |||
| Net cash provided by financing activities | |||
| Net decrease in cash and cash equivalents and restricted cash | |||
| Cash and cash equivalents and restricted cash at beginning of period | |||
| Cash and cash equivalents and restricted cash at end of period | |||
| Supplemental disclosure of cash flow information | |||
| Cash paid for interest | |||
| Supplemental cash flow information on non-cash investing and financing activities | |||
| Purchase of property and equipment included in accounts payable | |||
| Deferred financing costs in accounts payable and accrued expenses | |||
| Recognition of assumed warrant liability | |||
| Recognition of earn-out liabilities | |||
| Change in fair value of RTW Convertible Notes through OCI | |||
| Change in fair value of Revenue Interest Financing through OCI | |||
| Conversion of Series A Preferred Stock into Common Stock | |||
| Common stock issued for conversion of convertible notes | |||
| Exercise of PIPE Conversion Option |
Loading...